Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agilent Technologies (NY:A)

106.03 +1.03 (+0.98%)
Streaming Delayed Price Updated: 3:12 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Agilent Technologies

< Previous 1 2 3 4 5 6 7 8 9 Next >
Agilent Announces Acquisition of e-MSion, Early-Stage Company Behind ECD Technology that Helps Accelerate Drug Development
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Global Distribution Agreement with Proscia to Accelerate Data-Driven Precision Medicine
From Agilent Technologies Inc.
Via Business Wire
Agilent to Present at Barclays Global Healthcare Conference
From Agilent Technologies Inc.
Via Business Wire
Agilent Reports First-Quarter Fiscal Year 2023 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Bravo NGS Automated Liquid Handling Platform with On-Deck Thermal Cycler
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Cell Analysis Workflow Automation for Immuno-Oncology, Virology, and Vaccine Development Markets
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Cash Dividend of 22.5 Cents Per Share
From Agilent Technologies Inc.
Via Business Wire
Agilent Inspires at SLAS2023, Highlighting Innovative Automated Workflow Solutions
From Agilent Technologies Inc.
Via Business Wire
Colorado Governor Polis Helps Agilent Break Ground on $725 Million Expansion of Manufacturing Operations in Frederick
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance
From Agilent Technologies Inc.
Via Business Wire
Agilent to Announce First-Quarter Fiscal Year 2023 Financial Results Feb. 28
From Agilent Technologies Inc.
Via Business Wire
Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test
From Agilent Technologies Inc.
Via Business Wire
Agilent Included in Just Capital’s 2023 List of Most Just Companies
From Agilent Technologies Inc.
Via Business Wire
Agilent Authorizes $2 Billion Share Repurchase Program
From Agilent Technologies Inc.
Via Business Wire
Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
From Agilent Technologies Inc.
Via Business Wire
Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications
From Agilent Technologies Inc.
Via Business Wire
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
From Agilent Technologies Inc.
Via Business Wire
Agilent Resolution ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer
From Agilent Technologies Inc.
Via Business Wire
Agilent Again Named to Newsweek’s List of America’s Most Responsible Companies
From Agilent Technologies Inc.
Via Business Wire
Agilent Opens Customer Experience Center Highlighting Genomics and Diagnostics Solutions
From Agilent Technologies Inc.
Via Business Wire
Agilent Attains ‘Angel’ Level Sponsorship with My Green Lab
From Agilent Technologies Inc.
Via Business Wire
Agilent Deploys Next Generation Explosive Detection System at London Heathrow Airport
From Agilent Technologies Inc.
Via Business Wire
Agilent Reports Fourth-Quarter and Fiscal Year 2022 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Cash Dividend of 22.5 Cents Per Share
From Agilent Technologies Inc.
Via Business Wire
Agilent to Present at the Evercore ISI HealthCONx Conference
From Agilent Technologies Inc.
Via Business Wire
Agilent Remains In Buy Range Ahead Of Next Week's Q4 Report
S&P 500 component Agilent Technologies remains in buy range, holding above short-term moving averages, ahead of next week's Q4 earnings report. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Agilent Announces AssayMAP Bravo Protein Sample Prep Workbench 4.0
From Agilent Technologies Inc.
Via Business Wire
Agilent Joins the How2Recycle Program
From Agilent Technologies Inc.
Via Business Wire
Agilent to Announce Fourth-Quarter Fiscal Year 2022 Financial Results Nov. 21
From Agilent Technologies Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.